We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Diatron MI Plc

Develops, manufactures and markets hematology analyzers, clinical chemistry analyzers, and associated reagents for hu... read more Featured Products: More products

Download Mobile App





Diatron Displays New Hematology Analyzer at UAE Congress

By LabMedica International staff writers
Posted on 01 Aug 2017
Print article
Image: The Aquila 3-part differential hematology analyzer (Photo courtesy of Diatron).
Image: The Aquila 3-part differential hematology analyzer (Photo courtesy of Diatron).
Diatron (Budapest, Hungary), a global provider of hematology and clinical chemistry analyzers, displayed its newly developed Aquila 3-part differential hematology analyzer at the 69th AACC Annual Scientific Meeting & Clinical Lab Expo, the world’s largest exposition for clinical laboratory products and services.

Diatron develops, manufactures, and markets hematology and clinical chemistry analyzers, and associated reagents for human medical and veterinary use. The company was among over 750 exhibitors who displayed pioneering diagnostic technology, including the latest in mobile health, molecular diagnostics, mass spectrometry, point-of-care, and automation at the 2017 AACC Clinical Lab Expo held at the San Diego Convention Center from August 1-3.

Diatron’s new Aquila 3-part differential hematology analyzer (60 samples/hour throughput) has low reagent consumption (<12ml), requires only a small sample size (20ul) and has an on-board reagent pack (sufficient for approximately 200 measurements). Specifically designed for the de-centralized laboratory, the analyzer’s small footprint requires little bench space, allowing it to be used in several locations, including small laboratories as well as point-of-care applications. The analyzer features a large touch screen, an intuitive user interface, an optional back-up battery pack and extended connectivity options.

New
Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
New
MRSA/SA Detection Kit
MRSA/SA ELITe MGB Kit
New
Carcinoembryonic Antigen Test
CEA Test

Print article

Channels

Immunology

view channel
Image: Example image of the high-throughput microscopy method used in the study, showing immune cells stained with different fluorescence markers (Photo courtesy of Felix Kartnig/CeMM, MedUni Vienna)

Cutting-Edge Microscopy Technology Enables Tailored Rheumatology Therapies

Rheumatoid arthritis is the most common inflammatory joint disorder, with women three times as likely to suffer from the condition as men. Treatment advances made over the past decades have led to the... Read more

Microbiology

view channel
Image: RNA sequencing directly from whole blood aims to expand access to LRTI testing (Photo courtesy of CARB-X)

Novel Test to Diagnose Bacterial Pneumonia Directly from Whole Blood

Pneumonia and lower-respiratory-tract infections (LRTIs) are among the top causes of illness and death globally, particularly in vulnerable populations such as the elderly, young children, and immunocompromised... Read more

Pathology

view channel
Image: Lunit SCOPE HER2 is an AI-powered solution designed to detect HER2 expression profile (Photo courtesy of Lunit)

AI-Powered Pathology Solutions Accurately Predict Outcomes for HER2-Targeted Therapy in Metastatic CRC

A new study has highlighted how artificial intelligence (AI)-powered analysis of HER2 and the tumor microenvironment (TME) can improve patient stratification and predict clinical outcomes more effectively.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.